AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on April 17, 2026

Angiex Reports AACR In Vivo Data Supporting AGX101 in Combination With Immune Checkpoint Inhibitors for Solid Tumors
Stark Moving and Storage Takes Home 2026 Boston Business Excellence Award
Bob Grant, President of Grant Marketing, Earns Scaling AI Professional Certificate
Bodkin Design’s New Website Offers Free Exclusive Tools for Vision System Designers
VARStreet Gives End-Customers Real-Time Stock Visibility Directly on the eCommerce Store
New England to host first ever Amputee Soccer Open Cup in World Cup year
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
Hingham Savings Reports First Quarter 2026 Results
Acrivon to Highlight Preclinical Data with Three Posters at AACR Demonstrating Strong ACR-368 and ACR-2316 Synergies with Immune Checkpoint Inhibitors and ADC Payloads, Revealing Broad Clinical Development Opportunities
Crestwood Advisors Named Once Again to USA TODAY’s 2026 Best Financial Advisory Firms List
Pacemakers Market to Reach $7.5 Billion by 2030, Driven by Expanding Clinical Indications and Aging Demographics
Movers Near Me’ Searches Could Mislead Brookline Residents, Stark Moving and Storage Advises
ConnectM Delivers 93% Gross Profit Growth in Transformational Fiscal Year 2025; Targets $75 Million Revenue and Positive EBITDA for Fiscal Year 2026
First Steps Developmental Services Expands Services in Woburn
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC
Repligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network

Share this page:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.